Experiments were designed to separate effects of myocardial oxygen tension and oxygen consumption on coronary autoregulation. The approach was to measure coronary hemodynamic and metabolic responses to decreases in perfusion pressure during interventions that altered the balance between myocardial oxygen supply and demand. Studies were conducted in anesthetized heart-blocked dogs with the left coronary artery perfused from a pressure-controlled blood reservoir. Decreasing oxygen consumption by lowering heart rate from 120 to 40 bpm increased coronary venous oxygen tension and reduced the degree of flow autoregulation between 120 and 80 mm Hg by threefold. In contrast to effects of bradycardia, coronary constriction with vasopressin or indomethacin (heart rate 120 bpm), which produced comparable increases in baseline vascular resistance, decreased coronary venous oxygen tension, and augmented flow autoregulation by nearly twofold. Initial coronary venous oxygen tension but not oxygen consumption was strongly correlated with a quantitative index of autoregulation (-0.052 Po 2 + 2.01, R 2 = 0.86) over the pressure range of 120 to 80 mm Hg. When heart rate was lowered to 40 bpm and coronary venous oxygen tension subsequently reduced with vasopressin to control values (120 bpm), autoregulation was completely restored. Parallel studies examined the effects of metabolic and pharmacologic interventions on coronary pressure-flow relations over a wide range of pressures. For each 20 mm Hg decrement in pressure between 160 and 80 mm Hg, lowering heart rate attenuated autoregulation whereas pharmacologic coronary constriction augmented autoregulation. The observed variations in the autoregulation index were largely explained by differences in the prevailing venous oxygen tension. Furthermore, the upper pressure limit for autoregulation was dependent on venous oxygen tension with a threshold oxygen tension for autoregulation of 32 mm Hg.
in vascular smooth muscle regulates resistance in response to changes in transmural pressure. 19 " 21 Accordingly, a decrease in coronary artery pressure results in coronary vasodilation independent of changes in blood flow. It has been difficult to separate metabolic and myogenic mechanisms of autoregulation in the coronary circulation because changes in coronary perfusion pressure (myogenic stimulus) result in directionally similar transient changes in blood flow (metabolic stimulus). In addition, basal myocardial oxygen demands are high and metabolic factors could potentially mask or inhibit a myogenic response. 22 " 24 In this study we designed experiments to delineate the relative importance of metabolic factors in coronary autoregulation. The experimental approach was to determine the effects on coronary autoregulation of reducing myocardial oxygen demands by lowering heart rate. To separate effects of vascular resistance, myocardial Po 2 , and MVo 2 , we compared coronary autoregulation during vasoconstriction produced by lowering metabolic demands and by reducing myocardial blood flow with intracoronary infusion of vasopressin or indomethacin. This approach enabled us to define the relation between coronary autoregulation and coronary venous Po 2 .
Materials and Methods
Experiments were performed in 46 adult mongrel dogs (20-25 kg) . Animals were anesthetized with achloralose (100 mg/kg, IV), with additional doses of chloralose given as needed throughout the experiment.
The dogs were ventilated with oxygen-enriched room air to keep arterial Po 2 between 100 and 125 mm Hg and Pco 2 between 30 and 40 mm Hg. Arterial pH was maintained at 7. 35-7.45 by an intravenous infusion of sodium bicarbonate (150 mM, 5 ml/kg/hour, IV). 25 Aortic pressure was measured through a catheter inserted retrograde from the left femoral artery. Rectal temperature was held constant at 37° C.
The heart was exposed through a thoracotomy in the fifth left intercostal space. Complete atrioventricular heart block was produced by injection of 40% formalin (0.2 cc) directly into the atrioventricular node. 26 Pacing wires were sewn to the right ventricular outflow tract and connected to a stimulator. Intravenous lidocaine (1 mg/kg) was used in a few animals to suppress spontaneous ventricular escape beats during reductions in heart rate to 40 bpm.
Coronary Artery Perfusion
In 27 animals the left main coronary artery was perfused from a pressurized arterial reservoir through a metal cannula advanced through the right carotid artery. The cannula was tied in place with a ligature passed under the proximal coronary vessel. In 19 animals, the left anterior descending coronary artery was cannulated directly with a short stainless steel tube, secured with a ligature, and connected to the blood reservoir. Coronary artery pressure was measured at the cannula tip through an inner steel tube. Coronary blood flow was measured with an extracorporeal electromagnetic flow transducer (Zepeda Instruments, model SWF-4) in the coronary perfusion line. The reservoir blood was continually stirred and heated to maintain the temperature of the blood entering the cannula at 37° C. Reservoir blood volume was kept constant, and pressure in the reservoir was controlled with two compressed air sources connected in parallel. Heparin (initial dose 500 U/kg IV, then 250 U/kg IV every 1-2 hours) was given to prevent blood coagulation.
At the end of each experiment saturated Evans blue solution was injected into the coronary cannula to delineate the area of perfused myocardium which was removed and weighed to calculate coronary flow per 100 g of muscle mass. The flowmeter was calibrated by timed blood volume collections with blood from the experimental animal.
Measurement of Myocardial Oxygen Tension and
Oxygen Consumption ' Coronary venous Po 2 was used as an index of average tissue oxygen. For left main coronary artery preparations, the coronary sinus was cannulated with a 7F Sones angiographic catheter inserted through the right jugular vein with the catheter tip positioned 2-3 cm past the bend of the coronary sinus. 27 For left anterior descending coronary artery preparations, coronary venous blood waS sampled from the great cardiac vein within 1 cm of the origin of the anterior interventricular vein using a 6F Goodale Lubin angiographic catheter inserted through the jugular vein. Sampling of blood from this site reflects venous drainage from the perfusion territory of the left anterior descending artery. 28 Coronary arteriovenous oxygen difference was measured continuously by the spectrophotometric method of Shepherd and Burgar. 29 Blood was withdrawn simultaneously from the coronary venous catheter and arterial perfusion circuit upstream from the flow probe, pumped at a constant rate of 5 ml/minute through an arteriovenous oxygen difference spectrophotometer (Avox Systems, San Antonio, Texas) and returned to the animal through the right femoral vein. Accuracy of the arteriovenous oxygen difference spectrophotometer was confirmed in separate experiments in which coronary arteriovenous oxygen difference was varied over a wide range by changing perfusion pressure or by infusing adenosine or vasopressin into the coronary artery. A close correlation about the line of identity (r = 0.99) was found with measurements obtained using a Lex-O 2 -Con oxygen content analyzer (Lexington Instruments Corp., Walton, Mass.).
Total oxygen uptake (MVo 2 ) was calculated by multiplying the arteriovenous oxygen difference and coronary blood flow during steady state conditions. Coronary venous pH, Po 2 , and Pco 2 were measured with a blood gas analyzer (Instrumentation Laboratory Micro 13) calibrated daily with known gas mixtures. The accuracy of the blood gas analyzer over the Po 2 range of 5 to 50 mm Hg was checked using a tonometer (Instrumentation Laboratory Model 237) and equilibrating the dog's blood with known gas mixtures of nitrogen and oxygen. Measurements were accurate to within 1 mm Hg.
Quantitation of Coronary Autoregulation
The degree of coronary autoregulation was quantitated using an index (Arl) (Figure 1 ) which compares the observed change in vascular conductance for a given change in pressure to the calculated change in conductance assuming that flow remained constant. 23 A,,-(JL-Ji) (A_A)-= , -
where F, = initial flow at pressure P,, F = flow at pressure P, AF = F, -F, AP = P, -P. If conductance is unchanged or decreases when pressure is reduced (passive vascular bed), then Arl ^ 0 and there is no autoregulation. If conductance increases, then Arl > 0 and the degree of autoregulation will depend on the magnitude of the change in conductance with a maximum value for Arl of 1.0, indicating perfect autoregulation. Because MVo 2 decreased with reductions in coronary artery pressure and flow, the autoregulation index was adjusted for such changes in MVo 2 . Values of flow F at pressure P were corrected using the slope of the F vs MVo 2 relationship obtained by changing Heart rate (range 40 to 120 bpm). The corrected flow F c was calculated as where F m = measured flow, AMVo 2 (PF) = change in MVo 2 due to the decrease in P and F, AF/AMVo 2 = slope of the F vs MVo 2 relationship. Values for F c were used to calculate a corrected Arl which quantitates the degree of autoregulation at constant MVo 2 .
Experimental Protocols
After the preparation had stabilized for 30-45 minutes we recorded heart rate, mean aortic pressure, coronary artery pressure, mean and phasic coronary blood flow, and myocardial oxygen extraction. Coronary venous pressure, which was measured periodically during the course of each experiment, was 4 ± 2 (SE) mm Hg and never exceeded 8 mm Hg. In the first series of experiments, we determined the effects of reducing myocardial oxygen demands by lowering heart rate on coronary hemodynamic and metabolic responses to a step reduction in coronary artery pressure from 120to80mmHg. In 12 animals (8 left main, 4 left anterior descending preparations), control measurements were obtained at a heart rate of 120 bpm before and 5 minutes after reducing perfusion pressure. Preliminary studies demonstrated that all coronary hemodynamic and metabolic parameters had reached steady-state values 60-90 seconds following the pressure change. After returning coronary pressure to 120 mm Hg, heart rate was reduced to 40 bpm and the preparation allowed to stabilize for 10 minutes. All measurements were then repeated before and after reducing coronary pressure to 80 mm Hg. Heart rate was then increased to 120 bpm and the experimental protocol repeated.
To separate the effects of coronary vascular resistance, venous Po 2 , and MVo 2 on autoregulation, we compared coronary autoregulation during vasoconstriction produced by 1) decreasing MVo 2 by lowering heart rate, and 2) decreasing coronary blood flow with vasopressin or indomethacin at constant heart rate. We anticipated that lowering heart rate would increase coronary vascular resistance and decrease MVo 2 with little change or an increase in coronary venous Po 2 . In contrast, we expected that infusion of vasopressin or indomethacin at a heart rate of 120 bpm would increase coronary vascular resistance and decrease coronary venous Po 2 with little or no change in MVo 2 . In 8 animals (4 left main and 4 left anterior descending preparations), measurements were obtained at heart rates of 120, 40, and 120 bpm during intracoronary vasopressin infusion, and 45 minutes after discontinuing the vasopressin infusion. Lysine vasopressin was infused directly into the coronary perfusion line. The initial infusion rate (0.04-0.07 U/minute) was adjusted to decrease coronary blood flow at a heart rate of 120 bpm and pressure of 120 mm Hg to the flow rate observed at heart rate of 40 bpm before infusion of vasopressin. The concentration of vasopressin was held constant throughout the experiment by using a servo-controlled infusion pump (Harvard, Model 2990) coupled to the voltage output from the electromagnetic flowmeter. This permitted rapid adjustment of the drug infusion rate in proportion to changes in flow. In another group of 6 animals (3 left main and 3 left anterior descending preparations), a similar protocol was employed except that indomethacin was given to produce coronary vasoconstriction. 30 Indomethacin (5 mg/ml) was dissolved in saline and sodium carbonate and the pH adjusted to 7.0-7.5 with the addition of 1 N hydrochloric acid. Hemodynamic and metabolic measurements were obtained during control conditions and 45 minutes after intravenous administration of indomethacin (5 mg/kg).
A third series of experiments was performed to determine whether coronary autoregulation is coupled primarily to the level of myocardial oxygen consumption or to myocardial oxygen tension. If autoregulation depends mainly on tissue Po 2 , then lowering MVo 2 and reducing coronary venous Po 2 to control values should restore autoregulation. In 10 animals (6 left main and 4 left anterior descending coronary preparations), we measured coronary hemodynamic and metabolic responses to a decrease in perfusion pressure from 120 to 80 mm Hg at heart rates of 12p bpm (control), 40 bpm, and at 40 bpm during intracoronary infusion of vasopressin. The initial infusion rate of vasopressin (0.04-0.10 U/minute) was adjusted to restore coronary venous Po 2 to control values at a pressure of 120 mm Hg. Vasopressin concentration was maintained constant thereafter as described above.
In the final series of experiments we determined the influence of oxygen on both the degree of coronary autoregulation and the pressure range for autoregulation. In 10 animals (6 left main and 4 left anterior descending preparations), steady-state coronary artery pressure-flow relationships were obtained over the pressure range of 160-40 mm Hg by decreasing pressure in 20 mm Hg steps. Coronary hemodynamic and metabolic parameters were measured during steadystate conditions at each level of pressure. Pressureflow relations were obtained at heart rates of 120 bpm (control), 40 bpm, and 120 bpm during intracoronary administration of vasopressin. The initial infusion rate of vasopressin (0.04-0.08 U/minute) was adjusted to reduce coronary blood flow to control values at a pressure of 100 mm Hg (midpoint of the pressure-flow curve). Drug concentration was maintained constant thereafter as described above. Following each intervention, coronary hemodynamic and metabolic responses were repeated at a heart rate of 120 bpm and pressures of 120, 100, and 80 mm Hg. Only animals in which repeated measurements of all hemodynamic and metabolic parameters at 120 bpm were within 10% of the values obtained during the control pressure-flow curve were used for subsequent data analysis.
Data Analysis
In each series of experiments, we first tested whether the results obtained with the left main coronary artery preparation differed from those obtained with the left anterior descending coronary preparation using analysis of variance with artery (left anterior descending or left main), experimental intervention (heart rate, drug), coronary pressure, and dog as sources of variation. Because the effect of pressure did not differ significantly between arteries for a given experimental intervention, the data from left main and anterior descending preparations were combined for subsequent analysis.
Differences in effects of reducing coronary artery pressure on hemodynamic and metabolic parameters among experimental interventions were determined by analyses of variance using dogs as a randomized block. Differences were considered statistically significant at the/7<0.05 level using the Bonferroni method. The influence of metabolic factors on coronary autoregulation was assessed by regressing the autoregulation index (Arl) on coronary venous Po 2 , Pco 2 , or pH or on MVo 2 using analysis of covariance. For each covariable the data were best described using linear or quadratic functions as assessed by comparing standardized R 2 values and evaluating the statistical significance of higher-order terms. 31 Standardized R 2 values were used to compare the relative effect of the metabolic covariables on autoregulation.
Results

Effects of Lowering Heart Rate on Coronary Autoregulation
Following reduction in pressure at a heart rate of 120 bpm, coronary flow initially decreased and then returned toward control reaching a new steady state within 30 seconds (Figure 2 ). Oscillations in flow were usually observed prior to reaching steady state. Lowering heart rate from 120 bpm (top panel) to 40 bpm (bottom panel) decreased baseline diastolic flow from 80 to 55 ml/min/100 g. The dynamic and steady-state autoregulatory flow response to pressure reduction at the lower heart rate was markedly attenuated. Also, flow oscillations were observed less frequently and when present were of lower amplitude. Table 1 summarizes effects of heart rate on coronary hemodynamic and metabolic responses to decreasing perfusion pressure. Lowering heart rate from 120 to 40 bpm reduced myocardial oxygen consumption and increased coronary venous Po 2 . The autoregulation index (Arl) was reduced at 40 bpm ( Table 2) . Correction of flows at 80 mm Hg for the change in MVo 2 did not qualitatively alter effects of heart rate on pressureinduced changes in flow (Table 2) . Lowering heart rate reduced the corrected Arl by threefold from 0.56 ± 0 . 0 4 to 0.18 ± 0 . 0 5 (p<0.001).
Effects of Reducing Myocardial Oxygen Demands vs. Pharmacologic Vasoconstriction on Coronary Autoregulation
The effects of intracoronary infusion of vasopressin on coronary responses to decreasing perfusion pressure from 120 to 80 mm Hg are summarized in Table 3 . Vasopressin at heart rate 120 bpm decreased initial coronary flow to the same level observed at heart rate 40 bpm with a slight reduction in MVo 2 . In contrast to metabolic vasoconstriction, which increased coronary venous Po 2 and attenuated autoregulation, pharmaco- Venous Oxygen Tension and Coronary Autoregulation During Reduced Myocardial Oxygen Demands As in the previous groups of animals, lowering heart rate from 120 to 40 bpm decreased MVo 2 , increased coronary venous Po 2 , and decreased Arl. (See Table  5 .) Intracoronary infusion of vasopressin at a heart rate of 40 bpm further reduced coronary blood flow and venous Po 2 without altering MVo 2 , and increased Arl. At comparable levels of venous Po 2 , the Arl at a heart rate of 40 bpm was not significantly different from that at 120 bpm. Thus, while lowering MVo 2 attenuates coronary autoregulation, reducing venous Po 2 to control values completely restored autoregulation despite the low MVo 2 . This finding suggests that autoregulation is coupled to Po 2 rather than MVo 2 .
Coronary Pressure-Flow Relationships
Analysis of variance indicated that effects of pressure on coronary flow, arteriovenous O 2 difference, MVo 2 , and venous Po 2 did not differ significantly between the 6 left main and 4 left anterior descending coronary preparations for a given experimental condition. The effects of 20 mm Hg step reductions in coronary artery pressure from 160 to 40 mm Hg on coronary hemodynamic and metabolic parameters for all 10 animals are summarized in Figure 4 . Lowering heart Values are mean ± SE, n = 12. *p < 0.05 vs heart rate 120 bpm. 
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intracoronary vasopressin (VPN) (upper panels) and indomethacin (IND) (lower panels). Connected symbols represent individual points from each animal obtained at a heart rate (HR) of 120 bpm (o •), 40 bpm (A A), and at HR 120 bpm during pharmacologic coronary constriction (Q • ) .
Closed (solid) symbols indicate left main (LM) coronary artery preparations, and open symbols left anterior descending (LAD) preparations. In each group of animals there was a significant inverse correlation between venous P02 and autoregulation index, but only a weak association between Arl and MVo 2 .
rate from 120 to 40 bpm increased the slope of the pressure-flow curve between 160 mm Hg and 80 mm Hg whereas coronary constriction with vasopressin decreased the slope of the pressure-flow curve over this pressure range. Between 60 and 40 mm Hg the slope was less at heart rate 40 compared to that during vasopressin infusion. Coronary arteriovenous oxygen difference (A -VAo 2 ) increased linearly with decreasing coronary artery pressure at heart rate 120 bpm (slope -0 . 0 3 8 ±0.002). Lowering heart rate to 40 bpm increased the relative change in A -VAo 2 when pressure was reduced (slope -0.051 ± 0.003, p<0.001). In contrast, coronary constriction with vasopressin decreased the change in A -VAo 2 with pressure reduction (slope -0 . 0 1 9 ±0.002, p<0.001). Myocardial oxygen consumption fell as coronary artery pressure and flow were reduced during all three experimental conditions. Changes in MVo 2 tended to be less during vasopressin infusion over the pressure range of 120 to 80 mm Hg and greater between 60 and 40 mm Hg. During all 3 experimental conditions, coronary venous Po 2 fell linearly as coronary artery pressure was reduced. In Figure 5 , values for coronary flow were adjusted for pressure and flow related changes in MVo 2 . These flow values were used to construct pressure-flow relationships at constant MVo 2 (left panel) and to calculate the corrected autoregulation index for each 20 mm Hg change in pressure which was plotted as a function of initial pressure (right panel). Lowering heart rate attenuated the autoregulatory response for initial pressures between 160 and 80 mm Hg and decreased the upper pressure limit for autoregulation from 150 to 118 mm Hg (p<0.001). Vasopressin infusion augmented the autoregulatory response and increased the upper pressure limit for autoregulation to greater than 160 mm Hg (/?<.O1). Figure 6 plots the corrected autoregulation index for a 20 mm Hg reduction in pressure as a function of coronary venous Po 2 for each initial pressure (P,). Several observations can be made. First, there is a strong inverse relationship between the autoregulation index Values are mean + SE, n = 10. *p < 0.05 vs corresponding value at pressure 120 mm Hg. tp < 0.05 vs corresponding value at heart rate 120 bpm. $p < 0.05 vs corresponding value at heart rate 40 bpm. and initial venous Po 2 for each of the initial pressures between 160 and 100 mm Hg (R 2 = 0.63 -0 . 8 0 ) . Since the variation due to differences among dogs was small (R 2 = 0.05 -0.15), the observed effects of lowering heart rate and of vasopressin mediated constriction on coronary autoregulation ( Figure 5 ) can be largely explained by differences in prevailing venous Po 2 . Second, the venous Po 2 at which Arl is zero (threshold for autoregulation) for initial pressures between 160 and 100 mm Hg did not differ significantly (Po 2 = 30-34 mm Hg). Thus, the upper pressure limit for coronary autoregulation is strongly influenced by Discussion In this study experiments were designed to separate effects of coronary vascular resistance, MVo 2 , and myocardial (coronary venous) Po 2 on coronary autoregulation. A major rinding was that lowering heart rate from 120 to 40 bpm attenuated coronary autoregulation when perfusion pressure was reduced from 120 to 80 mm Hg (Figure 2 , Tables 1 and 2 ). In contrast to effects of bradycardia, coronary constriction resulting from vasopressin or indomethacin infusion augmented the autoregulatory response to pressure reduction (Tables 3 and 4). Since both metabolic and pharmacologic interventions produced comparable increases in baseline resistance but had qualitatively opposite effects on autoregulation, we conclude that changes in resistance cannot explain the attenuation of autoregulation during bradycardia.
In each of the animals studied, there was a strong inverse relationship between initial coronary venous Po 2 and the degree of coronary autoregulation (Arl) over the pressure range of 120-80 mm Hg. However, there was only a very weak association between MVo 2 and Arl (Figure 3 ). Such data suggest that the critical metabolic determinant of coronary autoregulation is myocardial Po 2 and riot MVo 2 . To further test the hypothesis that coronary autoregulation is coupled to myocardial Po 2 rather than MVo 2 , we compared autoregulatory responses at a control heart rate of 120 bpm and at 40 bpm before and after restoring venous Po 2 with vasopressin to control values. At comparable levels of venous Po 2 , Arl between 120 and 80 mm Hg was the same at both heart rates, despite significant differences in MVo 2 , evidence that autoregulation is coupled to Po 2 .
Additional evidence supporting a role for oxygen in coronary autoregulation is provided by the experiments examining effects of myocardial metabolic demands and of coronary vasoconstriction with vasopressin on coronary pressure-flow relations over a wide range of pressures. An important finding was that at each level of initial pressure between 160 and 100 mm Hg, there was a strong inverse relationship between the degree of autoregulation and coronary venous Po 2 ( Figure 6 ). Indeed, most of the variation in Arl associated with lowering heart rate or vasopressin mediated coronary constriction ( Figure 5 ) could be explained by differences in the prevailing venous Po 2 . The data indicate a threshold venous Po 2 for autoregulation of 30-34 mm Hg.
Interestingly, bradycardia and vasopressin mediated constriction had little effect on corrected Arl for pressure reduction below 80 mm Hg. While this could be interpreted to mean that oxygen is not important for autoregulation at low pressures, it is also possible that the effects of Po 2 are maximum at low flow rates. is only about half of that found for Po 2 under constant flow conditions. 33 The coronary vasodilator potency of CO 2 may be even less during free flow conditions. 36 In the present study, although coronary venous Pco 2 tended to increase when perfusion pressure was reduced from 120 to 80 mm Hg, the change of less than 2 mm Hg was not statistically significant and would be of insufficient magnitude to explain the observed decrease in resistance. Furthermore, a recent preliminary report indicated that the myocardial volume of distribution for CO 2 is considerably larger than for O 2 . 37 Following a 50% step decrease in coronary flow, coronary venous Po 2 reached 90% of its change in 13 seconds compared to 58 seconds for venous Pco 2 . This means that changes in tissue CO 2 are probably too slow to explain the rapid changes in vascular re-P,=60 30 50 sistance which occur during coronary autoregulation ( Figure 2 ).
Quantitation of Autoregulation
The autoregulation index (Arl) used in this study is the same as that employed by Norris et al. 23 The index compares the observed change in vascular conductance between two pressures to the calculated change in conductance assuming that flow remained constant. Based on this definition, autoregulation in response to a decrease in perfusion pressure occurs when conductance at the lower pressure is increased (or resistance decreased) compared to initial values. Such an approach to quantitating autoregulation differs from using the shape or slope of the pressure-flow curve. Differences between slopes of two pressure-flow seg-ments may not always indicate different degrees of autoregulation depending on initial pressure and flow (Figure 1 ). Also, a parallel shift in a pressure-flow relationship may not necessarily indicate that autoregulation is unchanged. This is because the slope of a pressure-flow curve is influenced not only by autoregulation but also by initial vasomotor tone. For example, in a markedly constricted vascular bed, the slope of a pressure-flow segment may be the same or less than that of a more vasodilated bed; however, the degree of autoregulation could be less if there is relatively little or no change in initial conductance or resistance.
Some of our studies used the cannulated left anterior descending coronary artery. The development of intraarterial pressure gradients could have resulted in collateral flow into or out of the region perfused by the left anterior descending artery. It is unlikely, however, that collateral flow significantly influenced the experimental results. The minimum intraarterial pressure gradient at which collateral flow can be detected with radiolabelled microspheres in the presence of forward flow is 60-85 mm Hg. 38 In the present study we did not observe pressure gradients of this magnitude in left anterior descending artery preparations in which coronary pressure was varied between 120 and 80 mm Hg (Tables 1-5 ). In the 10 animals used to examine coronary pressure-flow relations over the range of 160-40 mm Hg, intraarterial pressure gradients exceeding 60 mm Hg did occur at a coronary pressure of 160 mm Hg in the 4 left anterior descending artery preparations. However, in this and other protocols, the effects of pressure on coronary hemodynamic and metabolic parameters did not differ significantly between the left anterior descending and left main coronary artery preparations for a given experimental intervention.
One problem in attempting to quantitate coronary autoregulation is that decreasing coronary perfusion pressure and flow may result in a small reduction in MVoj even in the absence of myocardial ischemia (Gregg phenomenon 18 -39 ). Accordingly, any pressureinduced change in coronary flow would be influenced not only by the degree of autoregulation but also by the change in MVo 2 . To account for the effects of MVo 2 on autoregulation, data were also analyzed after adjusting coronary flow values for pressure and flow related changes in MVo 2 . The adjusted flow values were used to calculate a corrected autoregulation index which assumes constant MVo 2 . However, caution must be used in interpreting the corrected autoregulation index at low pressures, because changes in MVo 2 could be due, in part, to myocardial ischemia.
Another potential problem in interpreting the experimental results is that heart rate, in addition to altering MVo 2 , also affects the extravascular component of coronary vascular resistance which could influence autoregulation. However, when steady state diastolic flow (200 to 300 msec after the aortic dicrotic notch) was used instead of mean flow to calculate the autoregulation index, the effects of lowering heart rate and of pharmacological vasoconstriction on the diastolic Arl were qualitatively similar to results obtained using mean flow values. Thus, lowering heart rate significantly reduced diastolic Arl, and pharmacologic coronary vasoconstriction increased diastolic Arl. Furthermore, there was a strong inverse correlation between diastolic Arl and coronary venous Po 2 (R 2 = 0.94) over the pressure range of 120-80 mm Hg.
Although the autoregulation index provides a useful means of quantitating autoregulation, our major conclusions regarding the effects of oxygen on coronary autoregulation do not depend solely on this index. First, the dynamic flow response to a sudden reduction in pressure was dependent on the prevailing venous Po 2 . Thus, bradycardia which increased venous Po 2 attenuated the flow response to an abrupt decrease in pressure as evidenced by a slower rate of rise in flow (Figure 2) whereas vasopressin or indomethacin which decreased venous Po 2 resulted in a more rapid flow adjustment. Second, the absolute change in mean (and diastolic) coronary flow between pressures of 120 and 80 mm Hg during steady state conditions was greatest during bradycardia and high venous Po 2 and least during pharmacological vasoconstriction and low venous Po 2 (Tables 1-5 ). Finally, the shape of the pressureflow curve was altered by the experimental interventions, the slope being steeper at high venous Po 2 and flatter at low venous Po 2 ( Figure 5 ).
Consideration of Previous Studies
Schubert et al" measured tissue Po 2 with an oxygen microelectrode at two levels of perfusion pressure in the autoregulating isolated saline perfused cat heart. Decreasing coronary artery pressure from 113 to 78 mm Hg did not cause a statistically significant change in average tissue oxygen tension in those hearts which autoregulated. However, there were more locally hypoxic areas (tissue Po 2 ^ 5 mm Hg) at the lower perfusion pressure. These results were interpreted as being consistent with a common microvascular control mechanism which operates to achieve oxygen mass balance with locally hypoxic areas of the myocardium acting as a feedback signal for microvascular adjustments. Although these data would seem to rule out average tissue Po 2 as a mediator for coronary autoregulation, as Belloni has pointed out, 40 extrapolation to the in situ blood-perfused heart is limited by use of a high Po 2 -low oxygen content saline perfusate.
Recently, Drake-Holland et al 41 examined pressureflow relationships over the autoregulatory range at ventricular rates between 60 and 180 bpm. Reducing coronary perfusion pressure resulted in a decrease in coronary vascular resistance that was accompanied by a widening of the arteriovenous oxygen difference and a slight reduction in MVo 2 . Although the investigators state that heart rate shifted the entire pressure-flow curve in a nearly parallel fashion, close inspection of the curves (Figure 2 of that study) suggests that the slopes between 150 and 60 mm Hg may be greater at the lower heart rates (60-100 bpm) compared to the higher heart rates (140 and 180 bpm in that study indicates a progressive decrease from a value of 0.75 at the heart rate of 180 bpm to 0.31 at the heart rate of 60 bpm. Increasing heart rate resulted in metabolic vasodilation and was accompanied by a slight increase in arteriovenous oxygen difference and presumably a decrease in venous Po 2 . The investigators demonstrate a direct relation between coronary vascular resistance and venous oxygen content or tension. Such a relation has been previously demonstrated by Berne et al 42 for coronary sinus oxygen contents below 5.5 ml/100 ml. These observations are consistent with those in the present study and suggest that coronary autoregulation is closely coupled to myocardial Po 2 .
Implications Regarding Local Regulation of Myocardial Oxygenation
Based on the metabolic theory, myocardial metabolism provides a local feedback mechanism for maintaining tissue oxygenation following changes in oxygen supply or demand.
11718 Accordingly, vascular resistance (flow) and capillary exchange capacity (oxygen extraction) are modulated by changes in tissue Po 2 directly or through release of one or more vasoactive metabolites. The finding in the present study that autoregulation is closely coupled to venous Po 2 during changes in metabolic demands or oxygen delivery is consistent with such a metabolic mechanism. When venous Po 2 was relatively high (2: 32 mm Hg) pressure-induced changes in flow resulted in increases in oxygen extraction with little or no flow autoregulation. In contrast, as venous Po 2 was lowered below 32 mm Hg, the degree of flow autoregulation increased and the relative change in oxygen extraction decreased in response to reduction in perfusion pressure. The relative sensitivity of coronary resistance as well as exchange vessels to pressure-induced changes in flow would appear to depend on the prevailing venous Po 2 ( Figure 7 ). At high Po 2 myocardial oxygenation is regulated mainly by capillary exchange vessels, whereas at lower Po 2 the contribution of resistance vessels becomes more important. This observed influence of venous Po 2 on the relative contribution of resistance and exchange vessels to myocardial oxygenation is quite similar to that reported for skeletal muscle 43^* and intestine. 2347 - 48 In the resting skeletal muscle, the degree of flow autoregulation (venous Po 2 ^ 40 mm Hg) was found to be minimal. 45 However, when venous Po 2 was lowered during muscle contraction, catecholamine-induced vasoconstriction, or mild hypoxia, the degree of flow autoregulation following pressure reduction was significantly augmented. More recently, Sullivan and Johnson 49 measured arteriolar diameter and red blood cell velocity in individual microvessels of cat sartorius muscle when ambient oxygen tension and perfusion pressure were altered. Elevating ambient Po 2 reduced or abolished autoregulation in all orders of arterioles, consistent with the hypothesis that changes in tissue oxygen tension are responsible for autoregulation in skeletal muscle. A similar effect of ambient Po 2 on autoregulation has been reported in the cerebral circulation for cat pial vessels. 50 The myogenic hypothesis proposes that vascular resistance is proportional to transmural pressure presumably due to the effects of stretch on vascular smooth muscle. While our data for coronary autoregulation are consistent with a metabolic mechanism, they do not exclude a potential role for myogenic factors in autoregulation. However, the observation that metabolic and pharmacologic vasoconstriction have qualitatively opposite effects on coronary flow autoregulation is difficult to explain based on a myogenic mechanism unless myogenic induced vasodilation is facilitated at low venous Po 2 independent of the initial vascular resistance. Studies in intestine indicate that arterial hypoxia attenuates or has no effect on myogenic responses elicited by elevating venous pressure. 47 -5152 Although studies on the effects of metabolic rate on myogenic responses in the intestine are conflicting, 23 -48 a systematic study in skeletal muscle demonstrated that myogenic responses of resistance vessels were abolished when the resting muscle was stimulated to contract. 22 Recently, Khayyal et al 53 reported that pharmacologic coronary vasoconstriction with high-dose vasopressin that resulted in myocardial ischemia augmented coronary autoregulation. The investigators interpret the demonstration of autoregulation as well as reactive hyperemia in the presence of myocardial ischemia as evidence supporting a myogenic mechanism. An alternative explanation is that vasopressin reduced myocardial Po 2 and that subsequent reduction in coronary pressure and flow resulted in enhanced metabolic vasodilation.
In summary: The results of the present study indicate that coronary autoregulation is closely coupled to the prevailing coronary venous Po 2 and is facilitated at low Po 2 within the physiologic range. The findings are consistent with a metabolic mechanism for coronary autoregulation in which myocardial oxygen tension directly or through release of vasoactive metabolites results in coronary vasodilation when perfusion pressure is reduced.
